Intelligent Ultrasnd - Result of GM
30/11/2022 13:12
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221130:nRSd1134Ia&default-theme=true
RNS Number : 1134I Intelligent Ultrasound Group PLC 30 November 2022
Intelligent Ultrasound Group plc
(the "Group" or the "Company" or "Intelligent Ultrasound")
Results of General Meeting and Total Voting Rights
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic'
ultrasound company, specialising in artificial intelligence (AI) software and
simulation, announces that at the General Meeting held earlier today, all
resolutions proposed were duly passed on a poll by shareholders. A summary of
the voting results is shown below:
For Discretion Against Total Votes Cast % Voting For*
Withheld
Resolution 1 161,283,058 - 1,319 18,250 161,302,627 99.99
Resolution 2 161,283,058 - 1,319 18,250 161,302,627 99.99
* This column represents the number of votes that were cast for the
resolutions as a percentage of the number of votes cast in total for each
resolution either in person or by proxy.
Accordingly, the Company will raise a total of £5.2 million (before expenses)
via a Placing and Subscription through the issue and allotment of 56,216,220
new Ordinary Shares. An application has been made for the 27,028,752 EIS/VCT
Placing Shares to be admitted to trading on AIM, which is expected to take
place at 8.00 a.m. on 1 December 2022. A further application has been made for
the 15,475,360 General Placing Shares and 13,712,108 Subscription Shares to be
admitted to trading on AIM, which is expected to take place at 8.00 a.m. on 2
December 2022.
Following admission of both the EIS/VCT Placing Shares, the General Placing
Shares and the Subscription Shares, the Company's issued share capital of
326,869,705 will comprise Ordinary Shares, of which none are held in treasury.
The above figure of may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the voting rights of the
Company under the FCA's Disclosure Guidance and Transparency Rules.
Unless otherwise defined herein, capitalised terms used in this announcement
shall have the same meanings as defined in the circular sent to shareholders
of the Company on 11 November 2022.
Enquiries:
Intelligent Ultrasound Group plc www.intelligentultrasound.com (http://www.intelligentultrasound.com)
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cenkos Securities Tel: +44 (0)20 7397 8900
Giles Balleny / Max Gould (Corporate Finance)
Dale Bellis / Julian Morse (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
(mailto:intelligentultrasound@walbrookpr.com)
Anna Dunphy Mob: +44 (0)7876 741 001
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to
clinic' ultrasound companies, specialising in real-time hi-fidelity virtual
reality simulation for the ultrasound training market ('classroom') and
artificial intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market ('clinic'). Based in Cardiff in
the UK and Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through simulation.
Our main products are the ScanTrainer obstetrics and gynaecology training
simulator, the HeartWorks echocardiography training simulator,
the BodyWorks Eve Point of Care and Emergency Medicine training simulator
with Covid-19 module and the new BabyWorks Neonate and Paediatric training
simulator. To date over 1,400 simulators have been sold to c. 700 medical
institutions around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines smarter and more
accessible using our proprietary ScanNav ultrasound image analysis technology.
Current products on the market utilising this technology are GE
Healthcare's SonoLyst software that is incorporated in their Voluson Expert
22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer
that teaches real-time ultrasound-guided needling and incorporates ScanNav
Anatomy PNB.
www.intelligentultrasound.com (http://www.intelligentultrasound.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ROMBKKBDNBDDKDN